Mulazzani, Elisabeth
Zolyniak, Nicole
Noe, Elisabeth
Mulazzani, Matthias
Azad, Shahnaz Christina
Kümpfel, Tania
Kraft, Eduard
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC 1010 SyNergy)
Article History
Received: 12 February 2020
Accepted: 5 October 2020
First Online: 18 December 2020
Ethics approval and consent to participate
: Ethics approval for this observational study was obtained from the Ethics Commission of the Ludwig-Maximillian University, Klinikum Großhadern, Munich, Germany (project no: 600–15). Written informed consent according to local ethics committee guidelines of the Ludwig-Maximilian University were obtained from each individual patient in accordance with the Declaration of Helsinki.
: Not applicable.
: EM, NZ, EN, MM, SCA and EK report no disclosures. TK has received travel expenses and speaker honoraria from Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis/Genzyme, CLS Behring, Roche Pharma and Biogen as well as grant support from Bayer-Schering AG, Novartis and Chugai Pharma.